[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.184.210. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1953

EVALUATION OF FIVE NEW CYCLOPLEGIC DRUGS

Author Affiliations

PHILADELPHIA
From the Research and Refraction Departments of the Wills Hospital.

AMA Arch Ophthalmol. 1953;49(1):24-27. doi:10.1001/archopht.1953.00920020027004
Abstract

IN A SEARCH for an ideal cycloplegic agent, five new anticholinergic drugs have been evaluated at the Research and Refraction Departments of the Wills Hospital.

  1. Methantheline bromide (banthine®; β-diethylaminoethylxanthene-9-carboxylate methobromide)1

  2. D-2 (2,2-diphenyl-4-dimethylaminoethyl-1,3-dioxolane methobromide)2

  3. Three drugs all of which are esters of disubstituted acetic acids and are known for the time being as Compound 75 G. T., Compound 92 G. T., and Compound 93 G. T.3

PRESENT INVESTIGATION 

Drug Testing. 

  1. —Solutions were instilled into the conjunctival sac of the unanesthetized eye of white albino and chinchilla rabbits. The effect on the pupillary size and light reflex was observed. The duration of mydriasis was noted. If satisfactory mydriasis was produced with no local irritation, human studies were considered.

  2. Weak dilutions were instilled in human eyes, preferably eyes with blue irides.

  3. If cycloplegia was noted, then solutions of various strengths were used in the eyes of dark-skinned Negroes. The patients were given

First Page Preview View Large
First page PDF preview
First page PDF preview
×